We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.79B
AUM Growth
+$1.37B
Cap. Flow
+$258M
Cap. Flow %
2.63%
Top 10 Hldgs %
15.58%
Holding
2,579
New
256
Increased
680
Reduced
638
Closed
183

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Industrials 13.03%
3 Healthcare 12.4%
4 Financials 11.32%
5 Energy 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATL
251
DELISTED
National Interstate Corporation
NATL
$10.7M 0.11%
464,730
+317,501
+216% +$8.54M
AVY icon
252
Avery Dennison
AVY
$12.3B
$10.7M 0.11%
212,785
-28,030
-12% -$1.32M
ENDP
253
DELISTED
Endo International plc
ENDP
$10.7M 0.11%
158,260
-20,986
-12% -$1.2M
MEAS
254
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
$10.7M 0.11%
175,709
+32,705
+23% +$1.81M
HUB.B
255
DELISTED
HUBBELL INC CL-B
HUB.B
$10.5M 0.11%
96,793
-2,951
-3% -$315K
MCHP icon
256
Microchip Technology
MCHP
$42.8B
$10.5M 0.11%
468,544
-52,312
-10% -$1.1M
TT icon
257
Trane Technologies
TT
$106B
$10.5M 0.11%
170,153
-46,432
-21% -$2.56M
TNL icon
258
Travel + Leisure Co
TNL
$4.54B
$10.5M 0.11%
314,712
+109,195
+53% +$3.34M
NTGR icon
259
NETGEAR
NTGR
$669M
$10.4M 0.11%
317,173
+67,825
+27% +$2.11M
TMO icon
260
Thermo Fisher Scientific
TMO
$211B
$10.4M 0.11%
93,672
+30,729
+49% +$3.06M
ALL icon
261
Allstate
ALL
$66.9B
$10.2M 0.1%
187,784
-9,359
-5% -$499K
MRVL icon
262
Marvell Technology
MRVL
$174B
$10.2M 0.1%
711,331
+320,655
+82% +$4.13M
GSK icon
263
GSK
GSK
$103B
$10.1M 0.1%
151,367
+2,104
+1% +$136K
BIIB icon
264
Biogen
BIIB
$29.9B
$10M 0.1%
35,937
-233
-0.6% -$60.3K
PDCO
265
DELISTED
Patterson Companies, Inc.
PDCO
$10M 0.1%
243,103
+130,703
+116% +$5.42M
MTRX icon
266
Matrix Service
MTRX
$347M
$10M 0.1%
409,464
+77,762
+23% +$1.66M
MCRS
267
DELISTED
MICROS SYSTEMS INC
MCRS
$9.83M 0.1%
171,304
+28,658
+20% +$1.53M
SAH icon
268
Sonic Automotive
SAH
$3.15B
$9.62M 0.1%
393,004
+69,993
+22% +$1.63M
LH icon
269
Labcorp
LH
$24.3B
$9.6M 0.1%
122,320
-1,384
-1% -$118K
RPXC
270
DELISTED
RPX Corporation
RPXC
$9.58M 0.1%
567,021
+223,004
+65% +$3.79M
VTRS icon
271
Viatris
VTRS
$20.1B
$9.54M 0.1%
219,836
-239,787
-52% -$9.86M
APA icon
272
APA Corp
APA
$12.8B
$9.52M 0.1%
110,742
+2,071
+2% +$184K
GILD icon
273
Gilead Sciences
GILD
$161B
$9.45M 0.1%
125,865
-27,226
-18% -$1.9M
APTV icon
274
Aptiv
APTV
$12B
$9.41M 0.1%
156,570
-45,616
-23% -$2.64M
ETN icon
275
Eaton
ETN
$157B
$9.23M 0.09%
121,224
+29,713
+32% +$2.11M

Similar funds

Glenmede Trust's Q4 2013 Portfolio in Review

As of Q4 2013, Glenmede Trust held 2,579 positions worth $9.79B, up 16% from $8.42B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust's Q4 2013 filing shows 256 new, 680 increased, 638 reduced and 183 closed positions. Its largest new stake was Korn Ferry: 518,057 shares worth $13.5M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $20.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Glenmede Trust's largest Q4 2013 buy was Korn Ferry: 518,057 shares worth $13.5M.
  • Glenmede Trust added most to Stryker in Q4 2013, an estimated $31.5M increase.
  • Glenmede Trust's biggest Q4 2013 reduction was JPMorgan Chase, cutting an estimated $13.2M.
  • Glenmede Trust fully exited Vanguard FTSE All-World ex-US ETF in Q4 2013, selling an estimated $20.9M.
  • Glenmede Trust's ten largest holdings make up 16% of its $9.79B portfolio in Q4 2013.
  • Glenmede Trust opened 256 new positions and closed 183 in Q4 2013.
  • Glenmede Trust's portfolio value rose 16% quarter-over-quarter to $9.79B.

Based on Glenmede Trust's 13F filing for Q4 2013, filed 31 Jan 2014.